Pfizer Inc. (PFE)
Healthcare • Drug Manufacturers - General
StockNYSEUnited StatesUS7170811035
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Pfizer Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:40. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 02 Feb 2027 08:00 | 0.69 | — | — | Upcoming |
| 03 Nov 2026 06:00 | 0.74 | 0.87 | +18.3% | Beat |
| 04 Aug 2026 06:00 | 0.68 | 0.77 | +12.9% | Beat |
| 05 May 2026 06:00 | 0.72 | 0.75 | +3.9% | Beat |
| 03 Feb 2026 06:00 | 0.57 | 0.66 | +16.2% | Beat |
| 04 Nov 2025 07:00 | 0.63 | 0.87 | +37.4% | Beat |
| 05 Aug 2025 06:00 | 0.57 | 0.78 | +35.9% | Beat |
| 29 Apr 2025 06:00 | 0.67 | 0.92 | +36.5% | Beat |
| 04 Feb 2025 06:00 | 0.46 | 0.63 | +37.2% | Beat |
| 29 Oct 2024 06:00 | 0.61 | 1.06 | +73.3% | Beat |
| 30 Jul 2024 08:00 | 0.46 | 0.60 | +30.2% | Beat |
| 01 May 2024 06:00 | 0.51 | 0.82 | +60.1% | Beat |
| 30 Jan 2024 06:00 | -0.18 | 0.10 | +154.7% | Beat |
| 31 Oct 2023 06:00 | -0.34 | -0.17 | +50.0% | Beat |
| 01 Aug 2023 06:00 | 0.58 | 0.67 | +15.3% | Beat |
| 02 May 2023 06:00 | 0.99 | 1.23 | +24.7% | Beat |
| 31 Jan 2023 06:00 | 1.04 | 1.14 | +9.4% | Beat |
| 01 Nov 2022 06:00 | 1.40 | 1.78 | +27.0% | Beat |
| 28 Jul 2022 06:00 | 1.78 | 2.04 | +14.8% | Beat |
| 03 May 2022 06:00 | 1.57 | 1.62 | +3.5% | Beat |
| 08 Feb 2022 06:00 | 0.87 | 1.08 | +23.6% | Beat |
| 02 Nov 2021 06:00 | 1.09 | 1.34 | +23.5% | Beat |
| 28 Jul 2021 06:00 | 0.98 | 1.07 | +9.4% | Beat |
| 04 May 2021 06:00 | 0.78 | 0.93 | +19.6% | Beat |
| 02 Feb 2021 06:00 | 0.46 | 0.42 | -9.7% | Miss |
| 27 Oct 2020 06:00 | 0.71 | 0.72 | +1.0% | In line |
| 28 Jul 2020 06:00 | 0.66 | 0.78 | +18.1% | Beat |
| 28 Apr 2020 06:00 | 0.73 | 0.80 | +10.0% | Beat |
| 28 Jan 2020 06:00 | 0.58 | 0.55 | -4.5% | Miss |
| 29 Oct 2019 06:00 | 0.62 | 0.75 | +21.1% | Beat |
| 29 Jul 2019 06:00 | 0.75 | 0.80 | +6.0% | Beat |
| 30 Apr 2019 06:00 | 0.75 | 0.85 | +13.0% | Beat |
| 29 Jan 2019 06:00 | 0.63 | 0.64 | +1.0% | Beat |
| 30 Oct 2018 06:00 | 0.75 | 0.78 | +4.6% | Beat |
| 31 Jul 2018 06:00 | 0.74 | 0.81 | +8.9% | Beat |
| 01 May 2018 06:00 | 0.74 | 0.77 | +3.6% | Beat |
| 30 Jan 2018 06:00 | 0.56 | 0.62 | +10.5% | Beat |
| 31 Oct 2017 06:00 | 0.65 | 0.67 | +3.7% | Beat |
| 01 Aug 2017 06:00 | 0.66 | 0.67 | +1.7% | Beat |
| 02 May 2017 06:00 | 0.67 | 0.69 | +2.8% | Beat |
| 31 Jan 2017 06:00 | 0.51 | 0.47 | -7.1% | Miss |
| 01 Nov 2016 06:00 | 0.62 | 0.61 | -1.6% | Miss |
| 02 Aug 2016 06:00 | 0.62 | 0.64 | +2.8% | Beat |
| 03 May 2016 05:00 | 0.55 | 0.67 | +21.2% | Beat |
| 02 Feb 2016 06:00 | 0.52 | 0.53 | +1.4% | Beat |
| 27 Oct 2015 06:00 | 0.51 | 0.60 | +18.8% | Beat |
| 28 Jul 2015 07:00 | 0.52 | 0.56 | +8.6% | Beat |
| 28 Apr 2015 07:00 | 0.49 | 0.51 | +3.3% | Beat |
| 27 Jan 2015 07:00 | 0.53 | 0.54 | +2.3% | Beat |
| 28 Oct 2014 07:00 | 0.55 | 0.57 | +3.1% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 62.6B | -1.6% | 7.8B | 12.4% | 1.36 | -3.5% | 9.1B |
| 2024 | 63.6B | +6.8% | 8B | 12.6% | 1.41 | +281.1% | 9.8B |
| 2023 | 59.6B | -41.1% | 2.1B | 3.6% | 0.37 | -93.2% | 4.8B |
| 2022 | 101.2B | — | 31.4B | 31.0% | 5.47 | — | 26B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 29.59 | 29.77 | 28.62 | 28.71 | -2.32% | 141,319,166 | |
| 02 Nov 2026 – 06 Nov 2026 | 30.45 | 31.44 | 28.54 | 29.39 | -3.70% | 255,169,400 | 0.4300 |
| 26 Oct 2026 – 30 Oct 2026 | 30.00 | 30.67 | 29.22 | 30.52 | +1.63% | 158,239,900 | |
| 19 Oct 2026 – 23 Oct 2026 | 29.31 | 30.44 | 29.25 | 30.03 | +1.52% | 135,655,700 | |
| 12 Oct 2026 – 16 Oct 2026 | 28.42 | 29.88 | 28.13 | 29.58 | +4.60% | 146,281,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 27.65 | 28.29 | 27.12 | 28.28 | +1.73% | 155,939,400 | |
| 28 Sep 2026 – 02 Oct 2026 | 28.62 | 28.95 | 27.44 | 27.80 | -3.03% | 157,386,300 | |
| 21 Sep 2026 – 25 Sep 2026 | 27.65 | 28.85 | 27.49 | 28.67 | +3.65% | 151,776,100 | |
| 14 Sep 2026 – 18 Sep 2026 | 28.08 | 28.19 | 27.25 | 27.66 | -0.22% | 199,646,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 28.02 | 28.15 | 27.40 | 27.72 | -2.57% | 115,264,000 | |
| 253 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- AT&T or Pfizer: Only One Gets My Dividend Dollars for the Next 10 Years (opens in a new tab) TIKR · 11 Nov 2026 19:50
- “More Cancers Than Melanoma”: Moderna Is Up 750% in 2026. Take Profits, or Buy More? (opens in a new tab) TIKR · 11 Nov 2026 03:47
- Realty Income or Pfizer: Only One Gets My Dividend Dollars for the Next 10 Years (opens in a new tab) TIKR · 10 Nov 2026 17:54
- Pfizer (PFE) Posts Phase 3 ELREXFIO Win And Expands AI Research Push (opens in a new tab) Simply Wall St. · 10 Nov 2026 17:13
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (opens in a new tab) 10 Nov 2026 15:00
- GondolaBio gives new meaning to ‘sweat equity’ in rare R&D (opens in a new tab) Pharma Voice · 10 Nov 2026 15:00
- Pfizer’s comeback gets a new finance chief (opens in a new tab) Pharma Voice · 10 Nov 2026 14:09
- Pfizer Hits a New 52-Week High. Here's Why It's Not Too Late to Buy the Stock (opens in a new tab) Motley Fool · 10 Nov 2026 11:20
- Medicus Pharma Ltd (MDCX) Q3 2026 Earnings Call Highlights: Pfizer ADC License, SkinJet SPAC ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 05:03
- Pfizer (PFE) On A Higher 2026 Outlook Still Looks About Right (opens in a new tab) Simply Wall St. · 09 Nov 2026 22:10
- Pfizer (PFE) Stock Looks Overvalued On Its 29% One Year Gain (opens in a new tab) Simply Wall St. · 09 Nov 2026 21:09
- Why Pfizer Believes It Can Be a Leader in the GLP-1 Market, Even Though Its Drug May Not Debut Until 2028 (opens in a new tab) Motley Fool · 09 Nov 2026 15:05
- Medicus Pharma sharpens focus on Pfizer-licensed cancer drug CD228V, trims costs in Q3 (opens in a new tab) Proactive · 09 Nov 2026 13:33
- Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (opens in a new tab) Zacks · 09 Nov 2026 13:00
- What Happens To Pfizer Stock If Patent Losses Outpace New Drugs? (opens in a new tab) 09 Nov 2026 12:45
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 28.83 USD
- Market cap
- 165.4B
- Dividend yield
- 5.93%
- 5-year average yield
- 4.81%
- Payout ratio
- 246%
- Last dividend
- 0.4300 USD · 06 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 06 Nov 2026 | 0.4300 USD |
| 24 Jul 2026 | 0.4300 USD |
| 08 May 2026 | 0.4300 USD |
| 23 Jan 2026 | 0.4300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow PFE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.